(Q44971693)

7 December 2017

Frequent promoter methylation and gene silencing of CDH13 in pancreatic cancer (English)

1 reference

7 December 2017

0 references

Mitsuru Sakai

1

1 reference

7 December 2017

Kenji Hibi

2

1 reference

7 December 2017

Katsumi Koshikawa

3

1 reference

7 December 2017

Soichiro Inoue

4

1 reference

7 December 2017

Shin Takeda

5

1 reference

7 December 2017

Tetsuya Kaneko

6

1 reference

7 December 2017

Akimasa Nakao

7

1 reference

7 December 2017

language of work or name

1 reference

1 July 2004

1 reference

7 December 2017

1 reference

7 December 2017

95

1 reference

7 December 2017

7

1 reference

7 December 2017

588-591

1 reference

Genetic alterations in pancreatic carcinoma

7 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02491.X

Cadherins in cancer: implications for invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02491.X

The role of cell adhesion molecules in cancer invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02491.X

H-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02491.X

Cadherin-13, a mediator of calcium-dependent cell-cell adhesion, is silenced by methylation in chronic myeloid leukemia and correlates with pretreatment risk profile and cytogenetic response to interferon alfa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02491.X

The H-cadherin (CDH13) gene is inactivated in human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02491.X

5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02491.X

Frequent RASSF1A promoter hypermethylation and K-ras mutations in pancreatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02491.X

Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02491.X

Aberrant methylation of suppressor of cytokine signalling-1 (SOCS-1) gene in pancreatic ductal neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02491.X

A causal role for E-cadherin in the transition from adenoma to carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02491.X

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02491.X

Methylation status of p14ARF and p16INK4a as detected in pancreatic secretions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02491.X

10.1111/J.1349-7006.2004.TB02491.X

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference